Seok-Jong Lee Selected Research

Seok-Jong Lee Research Topics

Disease

8	Acne Vulgaris 04/2016 - 08/2005
6	Atopic Dermatitis (Atopic Eczema) 02/2022 - 05/2013
6	Inflammation (Inflammations) 09/2021 - 07/2008
5	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 02/2009
4	Cysts 08/2021 - 01/2007
4	Neoplasms (Cancer) 02/2021 - 02/2011
3	Alopecia (Baldness) 07/2020 - 08/2013
2	Nevus (Nevi) 08/2021 - 06/2017
2	Foreign-Body Reaction 10/2017 - 07/2016
2	Alopecia Areata 01/2017 - 10/2016
2	Hyperplasia 04/2016 - 01/2013
2	Postherpetic Neuralgia 12/2015 - 05/2011
2	Hemangioma (Angioma) 01/2015 - 08/2009
2	Melanoma (Melanoma, Malignant) 12/2013 - 06/2013
2	Infections 01/2013 - 04/2012
1	Dermatitis 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Psoriatic Arthritis 02/2019
1	Bites and Stings (Sting) 07/2016
1	Herpes Zoster 12/2015
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 11/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2015
1	Neoplasm Metastasis (Metastasis) 12/2013
1	Disease Progression 12/2013
1	Hyperhidrosis 04/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Tinea (Ringworm) 01/2013

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 09/2021 - 07/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 07/2008
2	Interleukin-17 (Interleukin 17)IBA 09/2021 - 02/2020
2	InterleukinsIBA 09/2021 - 02/2020
2	AcidsIBA 08/2016 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 04/2015
2	Staphylococcal enterotoxin AIBA 03/2014 - 05/2013
2	Interleukin-6 (Interleukin 6)IBA 12/2013 - 07/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 01/2013
2	Biological ProductsIBA 02/2009 - 07/2008
1	Particulate MatterIBA 02/2022
1	protectin D1IBA 09/2021
1	Imiquimod (Aldara)FDA LinkGeneric 09/2021
1	Adalimumab (Humira)FDA Link 08/2021
1	CeramidesIBA 07/2020
1	oleylamide (oleamide)IBA 07/2020
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 07/2020
1	SphingolipidsIBA 07/2020
1	AntibodiesIBA 02/2020
1	Interleukin-12 (IL 12)IBA 02/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Complex MixturesIBA 01/2020
1	Immunomodulating AgentsIBA 02/2019
1	Minoxidil (Rogaine)FDA LinkGeneric 02/2018
1	AllergensIBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Interleukin-33IBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017
1	polycaprolactoneIBA 10/2017
1	Calcifediol (Calcidiol)FDA Link 08/2017
1	Vitamin D FDA LinkGeneric 08/2017
1	diphenylcyclopropenoneIBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2016
1	Betamethasone (Celestone)FDA Link 10/2016
1	Peptides (Polypeptides)IBA 08/2016
1	glycyl-histidyl-lysineIBA 08/2016
1	IntegrinsIBA 04/2016
1	1,2,4,5-tetramethoxybenzeneIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	ChemokinesIBA 01/2016
1	HydrogelsIBA 11/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2015
1	SuspensionsIBA 06/2015
1	Timolol (Blocadren)FDA LinkGeneric 01/2015
1	Propranolol (Inderal)FDA LinkGeneric 01/2015
1	Dinitrochlorobenzene (DNCB)IBA 03/2014
1	SuperantigensIBA 03/2014
1	Cadherins (E-Cadherin)IBA 12/2013
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2013
1	salicylhydroxamic acid (SHAM)IBA 08/2013
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 06/2013
1	EnzymesIBA 05/2013
1	ImmunosorbentsIBA 05/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2013
1	Therapeutic UsesIBA 04/2013
1	Botulinum Toxins (Botulinum Toxin)IBA 04/2013
1	Tryptases (Tryptase)IBA 01/2013
1	FibrinIBA 01/2013

Therapy/Procedure

5	Therapeutics 10/2016 - 05/2011
2	Dye Lasers 01/2015 - 01/2012
2	Photochemotherapy (Photodynamic Therapy) 08/2012 - 01/2012
1	Lymph Node Excision (Lymph Node Dissection) 02/2021
1	Aftercare (After-Treatment) 06/2017
1	Solid-State Lasers 06/2017
1	Lasers (Laser) 04/2016
1	Oral Administration 01/2016
1	Pain Management 12/2015
1	Phototherapy (Light Therapy) 04/2015
1	Low-Level Light Therapy (LLLT) 08/2013
1	Sympathectomy (Sympathectomies) 04/2013